Evidence map›Paper›PMID 22984083›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Cutting edge: NADPH oxidase modulates MHC class II antigen presentation by B cells.

Victoria L Crotzer, Juan D Matute, Andrés A Arias, Heng Zhao, Lawrence A Quilliam, Mary C Dinauer, Janice S Blum

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. The Role of NADPH Oxidase 2 in Leukocytes.Antioxidants (Basel, Switzerland) · 2025
    Review
  6. A New Patient with p40Journal of clinical immunology · 2023
    Article
  7. Review
  8. Review
  9. AttenuatedVaccines · 2020
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Oncotarget · 2017
    Article
  18. NOX2-dependent regulation of inflammation.Clinical science (London, England : 1979) · 2016
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Victoria L CrotzerDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Juan D Matute
Andrés A Arias
Heng Zhao
Lawrence A Quilliam
Mary C Dinauer
Janice S Blum
Indiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Poxvirus Modulation of Immune ResponsesP01AI056097 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI BLUM, JANICE S · 2003 to 2010
$9.9M
Indiana Clinical and Translational Science Institute (UL1)UL1TR000006 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI SHEKHAR, ANANTHA · 2012 to 2013
$5.6M
Regulating hematopoietic stem cells and hematopoiesis for clinical efficacyP30DK090948 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI BROXMEYER, HAL E., SROUR, EDWARD F · 2010 to 2014
$3.7M
STRUCTURE/FUNCTION ANALYSIS OF PHAGOCYTE PROTEINSR01HL045635 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI DINAUER, MARY C · 1991 to 2009
$3.0M
CLASS II ANTIGEN PRESENTATION VIA CHAPERONE MEDIATED AUTOPHAGYR01AI079065 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI BLUM, JANICE S · 2010 to 2014
$1.8M
NCATS NIH HHS UL1 TR000006NCATS NIH HHS UL1 TR001108NHLBI NIH HHS R01 HL045635NHLBI NIH HHS R01 HL45635NIAID NIH HHS P01 AI056097NIAID NIH HHS R01 AI056097NIAID NIH HHS R01 AI079065NIDDK NIH HHS P30 DK090948
6 · The paper itself

Abstract

Phagocyte NADPH oxidase plays a key role in pathogen clearance via reactive oxygen species (ROS) production. Defects in oxidase function result in chronic granulomatous disease with hallmark recurrent microbial infections and inflammation. The oxidase's role in the adaptive immune response is not well understood. Class II presentation of cytoplasmic and exogenous Ag to CD4(+) T cells was impaired in human B cells with reduced oxidase p40(phox) subunit expression. Naturally arising mutations, which compromise p40(phox) function in a chronic granulomatous disease patient, also perturbed class II Ag presentation and intracellular ROS production. Reconstitution of patient B cells with a wild-type, but not a mutant, p40(phox) allele restored exogenous Ag presentation and intracellular ROS generation. Remarkably, class II presentation of epitopes from membrane Ag was robust in p40(phox)-deficient B cells. These studies reveal a role for NADPH oxidase and p40(phox) in skewing epitope selection and T cell recognition of self Ag.

Indexed as

Antigen PresentationB-Lymphocyte SubsetsCell Line, TransformedHLA-DR AntigensHumansIntracellular FluidLymphocyte ActivationNADPH OxidasesPhosphoproteinsReactive Oxygen SpeciesUp-RegulationHLA-DR AntigensNADPH Oxidasesneutrophil cytosol factor 40KPhosphoproteinsReactive Oxygen Species

Identifiers

PMID22984083
PMCPMC3466399
OpenAlexW2129375438

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.